This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2024 Med Learning Group. Built by Divigner. All Rights Reserved.
Patient Toolkit
Welcome to the STRIVE Patient Toolkit, a resource center for patients who have been diagnosed with Non-Hodgkin’s Lymphoma (NHL) to help them educate themselves about the disease and non-Hodgkin’s lymphoma treatment options, and become active participants while making healthcare decisions.
This NHL cancer patient toolkit provides links with information about diagnosis and non-Hodgkin’s lymphoma treatment options; advice on living with NHL including side effects, palliative care, and patient support; answers to frequently asked questions; and more.
If you have further questions about non-Hodgkin’s lymphoma treatment or general questions on NHL cancer after reading through the material, we encourage you to Talk to us!
This year (2022), more than 80,000 people (including children) will be diagnosed with Non-Hodgkin’s Lymphoma (NHL).1
This year (2022), more than 20,000 people will die of NHL.1
NHL is one of the more common cancers in children, teenagers, and young adults.1
Overall, 1 in 42 men and 1 in 52 women have a chance of being diagnosed with NHL.1
NHL is the seventh most prevalent cancer in the US.2
- Â American Cancer Society. https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/key-statistics.html
- Thandra KC, et al. Med Sci (Basel). 2021;9(1):5. https://pubmed.ncbi.nlm.nih.gov/33573146/
